Business · 13/01/2023
FDA Announces Draft Guidance for Dosage and Administration Section of Human Prescription Drug Labeling
The US Food and Drug Administration (FDA) is releasing a draft guidance to help pharmaceutical companies create clear and concise dosage and administration information for human prescription drugs and biological products, replacing a previous guidance issued in 2010.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →